Trent Ltd
TRENTTrent Ltd is coiled. The quarters are improving, yet the P/E sits at the 7th percentile of its own 10-year range — the business is moving before the market.
The sharpest disagreement: annual EPS moved +11.2% against a −42.0% price move — the market has not yet caught up with the delivery.
The price is building a base (6 weeks in) while the P/E sits at the 7th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +32.4% year on year, and 120% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Trent Ltd trades at ₹3,006, building a base and 6 weeks into that stage. That is +2.6% against its own 200-day average. It sits at 12% of a 52-week range of ₹2,734 to ₹5,080. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.
Today the stock is building a base — week 6 of stage 1. At ₹3,006 it trades +2.6% versus its 200-day average and sits at 12% of its 52-week range (₹2,734–₹5,080).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,989% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Trent Ltd trades at 92.8× P/E, near the bottom of its own range — cheaper only 7% of the time. Its long-run median P/E is 141.7×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 92.8× is near the bottom of its own range — cheaper only 7% of the time, against a long-run median of 141.7× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +11.2% against a −42.0% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 10y, of the +32.3%/yr price move, ~+41.7%/yr came from earnings growth and ~−9.4 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Trent Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 30.2% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +17.2% | +34.5% | +50.6% | +28.1% |
| Profit | +12.2% | +63.5% | — | +41.1% |
| EPS | +11.2% | +57.0% | — | +40.1% |
| Share price | −42.0% | +20.2% | +26.6% | +32.3% |
4-Factor Sector Score
54.8/100 — rank 10 of 26 in Textiles - Readymade Apparel · 89% evidence confidence
Trent Ltd scores 54.8 out of 100 against the 26 companies it is compared with in Textiles - Readymade Apparel, ranking 10. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 23 + 19.9 + 3.7 + 8.2 = 54.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Trent Ltd reported ₹5,028 Cr of revenue in the Mar 26 quarter, +19.2% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 28.1% a year. The last full year, FY26, came in at ₹20,074 Cr. The last four reported quarters add to ₹20,074 Cr.
FY26 revenue came in at ₹20,074 Cr (+17.2% on the year), capping 10 years at 28.1% compound. The latest quarter (Mar 26) printed ₹5,028 Cr, +19.2% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +17.2% growth against the decade's 28.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +17.2% over the last 4 quarters against +27.4%/yr over the last 8 — rolling over; TTM profit +12.1% vs +7.9%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Trent Ltd's operating margin is 18.0% in the Mar 26 quarter, +3.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 0.0% to 19.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 18.0%, +3.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 0.0%–19.0%, and FY26's 19.0% is the top of that band — a record year.
Why the margin moved: operating margin went +2.7 pp year on year while gross margin went +2.2 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Trent Ltd earned ₹413 Cr of net profit in the Mar 26 quarter, +32.4% year on year. It is the 4th consecutive quarter of growth. Full-year FY26 profit was ₹1,721 Cr. The 10-year compound rate is 41.1%. That is 8.2% of the quarter's revenue. The same quarter a year earlier earned ₹312 Cr.
Mar 26 profit was ₹413 Cr, +32.4% year on year — the 4th consecutive quarter of growth. On the full year, FY26 printed ₹1,721 Cr (+12.2%), and the 10-year compound rate is 41.1%.
Why profit moved: revenue contributed +19.2% and the margin +3.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +13.8% vs revenue +17.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 120% of Trent Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹2,668 Cr of operating cash against ₹1,721 Cr of profit. After ₹3,059 Cr of capital spending, ₹−391 Cr was left as free cash.
FY26: operating cash of ₹2,668 Cr against reported profit of ₹1,721 Cr, leaving free cash of ₹−391 Cr after ₹3,059 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 120% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 120%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Trent Ltd's cash conversion cycle runs 36 days in FY26, down from 40 days in FY21. Capital spending ran ₹4,071 Cr over the last 3 years. At FY26 sales of ₹20,074 Cr each day of that cycle holds about ₹55.0 Cr, so roughly ₹1,980 Cr sits inside the business at any moment.
FY26: debtors at 1 days, inventory at 74 days — roughly 2.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 36 days, tighter than FY21's 40.
The full loop: cash goes out to suppliers and production on day 0; stock waits 74 days to sell; customers pay about 1 days after that; and suppliers themselves are paid at 39 days — netting out to the 36-day cycle.
In money terms: at FY26 sales of ₹20,074 Cr, each day of the cycle holds about ₹55.0 Cr — so the 36-day loop keeps roughly ₹1,980 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹4,071 Cr over the last 3 fiscal years against ₹2,927 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹254 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Trent Ltd earns a ROCE of 28% in FY26. That is up from a trough of 1% in FY14. Return on invested capital clears the cost of that capital by +9.7 percentage points, so growth here adds value rather than only size. The wiring behind it is 8.6% net margin on 1.71× asset turns.
FY26 ROCE is 28%, recovered from a FY14 trough of 1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 8.6% net margin × 1.71× asset turns × 1.68× balance-sheet leverage ≈ 24.7% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 21.7% − 12.0% = a +9.7 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Trent Ltd carries total debt of ₹2,561 Cr against shareholder equity of ₹7,108 Cr as of Mar 26, a debt-to-equity of 0.36. On the annual view that ratio went from 1.96 in FY22 to 0.36 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹2,561 Cr against shareholder equity of ₹7,108 Cr — a debt-to-equity of 0.36. On the annual view, debt-to-equity went from 1.96 (FY22) to 0.36 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 12.7 points of Trent Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 15.1% of the company. Domestic institutions moved +9.9 points over the same window, to 23.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −12.7 points over 8 quarters to 15.1%; Domestic institutions: +9.9 points over 8 quarters to 23.1%; Promoters: +0.0 points over 8 quarters to 37.0%.
Why the register moved: rotation — foreign institutions −12.7 points against domestic institutions +9.9 points over 8 quarters, with promoters holding steady — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Trent Ltd: the Z-score reads 25.06. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 25.06 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 25.06.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Cantabil Retail India LtdCANTABIL | 68.7/100Favorable setup77% evidence | TURNING | 23.6/35 Revenue 18% · PAT 28% · OPM change 4 pp 83% evidence | 19.6/25 ROCE 19.1% · OPM 31% 95% evidence | 12.6/20 P/E 21.4× · PEG — 50% evidence | 12.9/20 RS sector 10.1% · RS bench -4.2% · 1Y -8.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 23.6 + 19.6 + 12.6 + 12.9 = 68.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2V2 Retail LtdV2RETAIL | 66.6/100Favorable setup79% evidence | LEADER | 28.6/35 Revenue 62.7% · PAT 100% · OPM change 2 pp 88% evidence | 15.3/25 ROCE 19.3% · OPM 14% 100% evidence | 9.4/20 P/E 56× · PEG — 15% evidence | 13.3/20 RS sector 5.4% · RS bench 2.5% · 1Y 13.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 28.6 + 15.3 + 9.4 + 13.3 = 66.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Kewal Kiran Clothing LtdKKCL | 66.3/100Favorable setup96% evidence | FADING | 19.7/35 Revenue 21.1% · PAT 2% · OPM change 1 pp 88% evidence | 18.5/25 ROCE 18.1% · OPM 19% 100% evidence | 16.4/20 P/E 21.6× · PEG 0.59 100% evidence | 11.7/20 RS sector 2.3% · RS bench -0.7% · 1Y -9.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 18.5 + 16.4 + 11.7 = 66.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Iris Clothings LtdIRISDOREME | 64.2/100Mixed-positive evidence87% evidence | LEADER | 22.3/35 Revenue 31.8% · PAT 31.9% · OPM change 3 pp 95% evidence | 14.3/25 ROCE 16% · OPM 17% 95% evidence | 7.6/20 P/E 57.4× · PEG — 50% evidence | 20.0/20 RS sector 53% · RS bench 48.9% · 1Y 73.8%11 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 14.3 + 7.6 + 20 = 64.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5SBC Exports LtdSBC | 58.7/100Mixed-positive evidence83% evidence | LEADER | 26.2/35 Revenue 34.4% · PAT 86.6% · OPM change -0.6 pp 83% evidence | 11.5/25 ROCE 18.2% · OPM 4.2% 95% evidence | 6.7/20 P/E 79.2× · PEG — 50% evidence | 14.3/20 RS sector 39.5% · RS bench 36.9% · 1Y 141.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.2 + 11.5 + 6.7 + 14.3 = 58.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Pearl Global Industries LtdPGIL | 58.7/100Mixed-positive evidence78% evidence | BREAKING OUT | 16.0/35 Revenue 11.5% · PAT 17.3% · OPM change 0 pp 83% evidence | 16.9/25 ROCE 19.9% · OPM 10% 76% evidence | 7.2/20 P/E 34.7× · PEG — 50% evidence | 18.6/20 RS sector 33% · RS bench 29.8% · 1Y 35.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 16.9 + 7.2 + 18.6 = 58.7 · Decision use: Price leads the evidence: RS versus the benchmark is 29.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7V-Mart Retail LtdVMART | 58.3/100Mixed-positive evidence93% evidence | BREAKING OUT | 25.6/35 Revenue 19.1% · PAT 100% · OPM change 1 pp 100% evidence | 7.2/25 ROCE 13.2% · OPM 15% 100% evidence | 7.3/20 P/E 44.7× · PEG 2.5 65% evidence | 18.2/20 RS sector 13.8% · RS bench 10% · 1Y -3.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.6 + 7.2 + 7.3 + 18.2 = 58.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8S P Apparels LtdSPAL | 57.0/100Mixed-positive evidence96% evidence | LEADER | 14.9/35 Revenue 13.2% · PAT 8.5% · OPM change -2 pp 88% evidence | 12.5/25 ROCE 14% · OPM 12% 100% evidence | 11.7/20 P/E 24.7× · PEG 0.69 100% evidence | 17.9/20 RS sector 28.9% · RS bench 25.4% · 1Y 19.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 12.5 + 11.7 + 17.9 = 57 · Decision use: Price leads the evidence: RS versus the benchmark is 25.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Monte Carlo Fashions LtdMONTECARLO | 56.3/100Mixed-positive evidence69% evidence | ASLEEP | 22.6/35 Revenue 15.9% · PAT 38.1% · OPM change 6.5 pp 62% evidence | 9.5/25 ROCE 14% · OPM 9.2% 95% evidence | 14.5/20 P/E 9.7× · PEG — 50% evidence | 9.7/20 RS sector 0% · RS bench -14.5% · 1Y -12.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 22.6 + 9.5 + 14.5 + 9.7 = 56.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Trent Ltdthis pageTRENT | 54.8/100Mixed-positive evidence89% evidence | TURNING | 23.0/35 Revenue 17.1% · PAT 12.1% · OPM change 3 pp 88% evidence | 19.9/25 ROCE 28.3% · OPM 18% 100% evidence | 3.7/20 P/E 92.8× · PEG 6.56 65% evidence | 8.2/20 RS sector -21.8% · RS bench 1.5% · 1Y -40.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23 + 19.9 + 3.7 + 8.2 = 54.8 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 11Arvind Fashions LtdARVINDFASN | 53.7/100Mixed-positive evidence93% evidence | TURNING | 23.5/35 Revenue 14% · PAT 100% · OPM change 0 pp 100% evidence | 14.9/25 ROCE 19.6% · OPM 12% 100% evidence | 8.9/20 P/E 45.9× · PEG 1.95 65% evidence | 6.4/20 RS sector -4.5% · RS bench -7.5% · 1Y -10%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.5 + 14.9 + 8.9 + 6.4 = 53.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -4.5% and the one-year return is -10%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Aditya Birla Lifestyle Brands LtdABLBL | 51.7/100Mixed-positive evidence78% evidence | ASLEEP | 20.0/35 Revenue 9.1% · PAT 100% · OPM change 1 pp 100% evidence | 12.0/25 ROCE 15% · OPM 15% 100% evidence | 11.4/20 P/E 54.1× · PEG 1.39 65% evidence | 8.3/20 RS sector — · RS bench -19% · 1Y -35.1%0 of 10 weeks ahead 25% evidence |
| Exact sum: 20 + 12 + 11.4 + 8.3 = 51.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Thomas Scott India LtdTHOMASCOTT | 51.0/100Thin evidence · provisional54% evidence | 18.2/35 Revenue 61.5% · PAT 54.4% · OPM change -0.4 pp 53% evidence | 15.1/25 ROCE 20.4% · OPM 11.8% 71% evidence | 11.0/20 P/E 21× · PEG — 15% evidence | 6.7/20 RS sector -5.2% · RS bench -17.3% · 1Y -25.7%1 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 18.2 + 15.1 + 11 + 6.7 = 51 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Credo Brands Marketing LtdMUFTI | 50.9/100Mixed-positive evidence63% evidence | FADING | 13.5/35 Revenue 0% · PAT -3.4% · OPM change -2 pp 45% evidence | 17.0/25 ROCE 19.1% · OPM 29% 71% evidence | 12.6/20 P/E 7.7× · PEG — 50% evidence | 7.8/20 RS sector -12.7% · RS bench -15.7% · 1Y -49.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 17 + 12.6 + 7.8 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Vishal Mega Mart LtdVMM | 50.5/100Mixed-positive evidence87% evidence | ASLEEP | 23.8/35 Revenue 19.8% · PAT 29.6% · OPM change 0 pp 100% evidence | 11.8/25 ROCE 14.8% · OPM 15% 100% evidence | 4.7/20 P/E 56.2× · PEG 5.39 65% evidence | 10.2/20 RS sector 2.7% · RS bench -17.7% · 1Y -23.5%3 of 10 weeks ahead 70% evidence |
| Exact sum: 23.8 + 11.8 + 4.7 + 10.2 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Bella Casa Fashion & Retail LtdBELLACASA | 50.2/100Mixed-positive evidence61% evidence | 22.4/35 Revenue 21.8% · PAT 37% · OPM change -0.3 pp 53% evidence | 12.7/25 ROCE 17.2% · OPM 8.7% 71% evidence | 11.2/20 P/E 16.6× · PEG — 50% evidence | 3.9/20 RS sector -20.8% · RS bench -31.3% · 1Y -41.5%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 22.4 + 12.7 + 11.2 + 3.9 = 50.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Vedant Fashions LtdMANYAVAR | 47.5/100Mixed-negative evidence90% evidence | ASLEEP | 9.9/35 Revenue 2.4% · PAT 0.8% · OPM change -0.7 pp 88% evidence | 19.4/25 ROCE 30.7% · OPM 33.8% 100% evidence | 14.4/20 P/E 25× · PEG 1.61 100% evidence | 3.8/20 RS sector -32% · RS bench -22.2% · 1Y -47.4%3 of 10 weeks ahead 70% evidence |
| Exact sum: 9.9 + 19.4 + 14.4 + 3.8 = 47.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 18Sai Silks (Kalamandir) LtdKALAMANDIR | 47.1/100Mixed-negative evidence81% evidence | ASLEEP | 13.3/35 Revenue 4.8% · PAT 20.2% · OPM change -1 pp 95% evidence | 15.4/25 ROCE 14.4% · OPM 14% 95% evidence | 14.4/20 P/E 10× · PEG — 50% evidence | 4.0/20 RS sector -16.9% · RS bench -33.5% · 1Y -51.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 15.4 + 14.4 + 4 = 47.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 19Lux Industries LtdLUXIND | 38.6/100Mixed-negative evidence78% evidence | ASLEEP | 10.1/35 Revenue 13.4% · PAT -35.8% · OPM change -2 pp 83% evidence | 7.8/25 ROCE 8.1% · OPM 7% 76% evidence | 9.0/20 P/E 34.6× · PEG — 50% evidence | 11.7/20 RS sector 5.9% · RS bench 2.6% · 1Y -11.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 10.1 + 7.8 + 9 + 11.7 = 38.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Baazar Style Retail LtdSTYLEBAAZA | 35.8/100Mixed-negative evidence71% evidence | ASLEEP | 18.1/35 Revenue 37% · PAT 100% · OPM change -2 pp 65% evidence | 6.3/25 ROCE 7.4% · OPM 10% 100% evidence | 8.6/20 P/E 93.9× · PEG — 15% evidence | 2.8/20 RS sector -13.1% · RS bench -15.6% · 1Y 0.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 6.3 + 8.6 + 2.8 = 35.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Raymond Lifestyle LtdRAYMONDLSL | 35.4/100Mixed-negative evidence68% evidence | ASLEEP | 17.6/35 Revenue 9.2% · PAT 4.9% · OPM change 1 pp 74% evidence | 2.0/25 ROCE 3.5% · OPM 6% 100% evidence | 10.2/20 P/E 29× · PEG — 15% evidence | 5.6/20 RS sector -8.1% · RS bench -26.6% · 1Y -35.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.6 + 2 + 10.2 + 5.6 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Go Fashion (India) LtdGOCOLORS | 30.5/100Adverse evidence81% evidence | TURNING | 4.7/35 Revenue -1.6% · PAT -39.1% · OPM change -4 pp 95% evidence | 10.2/25 ROCE 10.6% · OPM 27% 95% evidence | 12.3/20 P/E 32.2× · PEG — 50% evidence | 3.3/20 RS sector -47.6% · RS bench -28.4% · 1Y -61.9%7 of 10 weeks ahead 70% evidence |
| Exact sum: 4.7 + 10.2 + 12.3 + 3.3 = 30.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Aditya Birla Fashion & Retail LtdABFRL | 30.2/100Adverse evidence61% evidence | ASLEEP | 12.6/35 Revenue 11.2% · PAT -80% · OPM change -3 pp 62% evidence | 3.9/25 ROCE -3.1% · OPM 9% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.7/20 RS sector -13% · RS bench -15.9% · 1Y -18.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.6 + 3.9 + 10 + 3.7 = 30.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Gokaldas Exports LtdGOKEX | 28.3/100Adverse evidence90% evidence | TURNING | 8.5/35 Revenue 3.2% · PAT -36.7% · OPM change -1 pp 88% evidence | 8.1/25 ROCE 8.4% · OPM 11% 100% evidence | 1.9/20 P/E 59.6× · PEG 4.98 100% evidence | 9.8/20 RS sector -6.8% · RS bench 7.5% · 1Y -9.6%8 of 10 weeks ahead 70% evidence |
| Exact sum: 8.5 + 8.1 + 1.9 + 9.8 = 28.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Kitex Garments LtdKITEX | 22.5/100Adverse evidence65% evidence | ASLEEP | 3.9/35 Revenue -32.1% · PAT -80% · OPM change -16 pp 83% evidence | 4.5/25 ROCE 1.5% · OPM 1% 76% evidence | 8.5/20 P/E 290× · PEG — 15% evidence | 5.6/20 RS sector -9.2% · RS bench -19.1% · 1Y -44%0 of 10 weeks ahead 70% evidence |
| Exact sum: 3.9 + 4.5 + 8.5 + 5.6 = 22.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Karnika Industries LtdKARNIKA | 59.8/100Thin evidence · provisional48% evidence | ASLEEP | 20.3/35 Revenue — · PAT — · OPM change 2.3 pp 19% evidence | 20.9/25 ROCE 51.2% · OPM 17.2% 95% evidence | 10.4/20 P/E 26.1× · PEG — 15% evidence | 8.2/20 RS sector -2.4% · RS bench -16.3% · 1Y -16.7%5 of 10 weeks ahead 70% evidence |
| Exact sum: 20.3 + 20.9 + 10.4 + 8.2 = 59.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Trent Ltd's share price today?
Trent Ltd trades at ₹3,006, −42.0% over the past year. The company is valued at ₹1,60,284 Cr. The stock sits at 12% of its 52-week range of ₹2,734–₹5,080, +2.6% versus its 200-day average. On the tape, the price is building a base, 6 weeks in. — as of 31 July 2026.
What were Trent Ltd's latest quarterly results?
Trent Ltd reported revenue of ₹5,028 Cr and net profit of ₹413 Cr for the Mar 26 quarter. Revenue rose 19.2% and profit rose 32.4% year on year. Earnings per share were ₹7.51. The operating margin was 18.0%, 3.0 pp higher than a year earlier. — as of 31 July 2026.
What is Trent Ltd's revenue?
Trent Ltd reported revenue of ₹5,028 Cr in the Mar 26 quarter, +19.2% year on year. For the full FY26 fiscal year, revenue was ₹20,074 Cr (+17.2%). Over the last 10 years revenue compounded at 28.1% a year. — as of 31 July 2026.
What is Trent Ltd's profit?
Trent Ltd earned ₹413 Cr of net profit in the Mar 26 quarter, +32.4% year on year — the 4th straight quarter of growth. Full-year FY26 profit was ₹1,721 Cr. The operating margin ran 18.0% in the latest quarter. — as of 31 July 2026.
What is Trent Ltd's market cap?
Trent Ltd's market capitalisation is ₹1,60,284 Cr at a share price of ₹3,006. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Trent Ltd's P/E ratio?
Trent Ltd trades at a P/E of 92.8×, at the 7th percentile of its own 10-year range, against a long-run median of 141.7×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Trent Ltd pay a dividend?
Yes — Trent Ltd's dividend payout was 8% of profit in FY26, and it recorded a payout in 11 of its last 13 reported fiscal years. 2 of those years show a negative ratio because profit itself was negative. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Trent Ltd overvalued?
On its own history, Trent Ltd looks cheap against its own history: its P/E of 92.8× has been cheaper only 7% of the time in 10 years (long-run median 141.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 31 July 2026.
Is Trent Ltd growing?
Yes — Trent Ltd is growing: latest-quarter revenue +19.2% year on year, profit +32.4%, and the margin +3.0 pp at 18.0%. The 10-year compound rates are 28.1% (revenue) and 41.1% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Trent Ltd performing?
Trent Ltd is building a base, 6 weeks in. Its latest quarter's revenue rose 19.2% and profit rose 32.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Trent Ltd in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROCE at 30.2% and holding. The read comes from the last 12 quarters of growth (revenue growth +17.2% latest, profit growth +12.1% latest, eps growth +11.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Trent Ltd in an uptrend?
No — the price is building a base (week 6 of stage 1), trading +2.6% versus its 200-day average and at 12% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Trent Ltd beating the market?
On recent form, yes — Trent Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,989% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Trent Ltd's share price go up?
This page publishes no price forecast for Trent Ltd. What it measures instead: the share price is ₹3,006, the price is building a base 6 weeks in. Its P/E of 92.8× sits at the 7th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 31 July 2026.
Who owns Trent Ltd?
Promoters hold 37.0% of Trent Ltd, foreign institutions 15.1%, domestic institutions 23.1% and the public 24.6% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 12.7 points over 8 quarters. — as of 31 July 2026.
Does Trent Ltd have too much debt?
It is moderate — Trent Ltd's debt-to-equity is 0.37, and operating profit covers the interest bill 16×. FY26 borrowings were ₹2,561 Cr against equity of ₹6,985 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Trent Ltd's capex?
Trent Ltd spent ₹4,071 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹3,059 Cr, with ₹254 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Trent Ltd's cash flow?
Trent Ltd generated ₹2,668 Cr of operating cash flow in FY26 and ₹−391 Cr of free cash flow after ₹3,059 Cr of capital spending. Reported profit that year was ₹1,721 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Trent Ltd's profit real cash?
Yes — over the last 3 fiscal years, 120% of Trent Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹2,668 Cr against reported profit of ₹1,721 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
How financially safe is Trent Ltd?
On the balance sheet, the Z-score reads 25.06 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 31 July 2026.
Where is Trent Ltd in its business cycle?
Trent Ltd's FY26 operating margin was 19.0%, against a 13-year band of 0.0%–19.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 18.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Trent Ltd story?
The sharpest disagreement: annual EPS moved +11.2% against a −42.0% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Trent Ltd a stock worth studying right now?
This is not investment advice. The machine read: Trent Ltd is coiled. The quarters are improving, yet the P/E sits at the 7th percentile of its own 10-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.